(2) when there is a raised concentration of lactate dehydrogenase. The latter would cause changes in optical density before the addition of the 3-hydroxybutyrate dehydrogenase, and is due to the conversion of plasma pyruvate to lactate with accompanying utilization of NADH. In this situation perchloric acid extraction would have to be performed.
Summary Treatment with oral diazoxide for periods of 4 to 10 weeks in hospital allowed adequate control of hypertension with continuation of fetal growth in four patients with severe toxaemia. Two were insulin-dependent diabetics and one of these suffered from renal failure. In all patients albuminuria diminished markedly, while the fluid retention was controlled with frusemide. Three pregnancies were successfully terminated by lower segment caesarean section and in the remaining case vaginal delivery resulted in the birth of a healthy baby. Control of blood sugars presented no problems in the diabetic patients.
Only minimal adjustments of insulin dosage were required. One of the non-diabetic patients developed mild hyperglycaemia which responded to tolbutamide. The maintenance of adequate placental perfusion and renal function. Conventional therapy achieves only the first of these objectives. Intravenous diazoxide has been reported by Finnerty (1962) to produce favourable results in toxaemia of pregnancy. We wish to report the successful use of oral diazoxide in four patients presenting with severe toxaemia of pregnancy (see Table) .
Case 1
A 24-year old insulin-dependent diabetic of 12 years' standing was first documented as having albuminuria with mild hypertension eight years previously. She presented to thishospital in June 1970 in the third month of her second pregnancy with a blood pressure of 130/ 90 mm Hg, proteinuria, but without oedema or retinopathy. Her blood urea was 28 mg/100 ml. In July 1970 at 17 weeks her blood urea had risen to 54 mg/ 100 ml, and the serum creatinine was 2-0 mg/ 100 ml.
Early in August she was readmitted with a haemoglobin of 9 0 g/ 100 ml, for a total dose infusion of Imferon. This was ineffective, however, and by the end of September, when her haemoglobin had fallen to 7-2 g/100 ml, she was transfused with 2 pints (1,140 ml) of packed cells. Later in August her final admission was precipitated by progressive hypertension (135/100), increasing albuminuria, and the development of dependent oedema. Retinal haemorrhages were observed for the first time.
She was treated with heavy sedation and strict bed rest, but did not improve. In September, at the twenty-sixth week of pregnancy, her blood pressure was 180/110, and she had generalized oedema, hydramnios, a raised jugular venous pressure, and hepatomegaly. There were fresh haemorrhages in both fundi. The blood urea was 54 mg/ 100 ml, the urinary protein leak was 4 g per 24 hours and the serum albumin was 2 9g/100 ml. Termination of pregnancy was considered but a trial of diazoxide was held to be a justifiable alternative. Treatment with oral diazoxide 50 mg three times a day increasing to 100 mg four times a day was begun and her blood pressure fell to 110/70 and was maintained near that level for the remaining 10 weeks of her pregnancy. Her urinary protein leak fell to 0-5 to 1 g a day. The fluid retention was overcome by the use of up to 200 mg of frusemide daily but there was no consistent effect on the hydramnios.
The diabetic control was maintained with twice-daily injections of a mixture of soluble and isophane insulin. After the introduction of diazoxide an increase from 4 to 8 units total daily dose of insulin was required. The only discomfort the patient suffered during the remainder of her pregnancy was the well-known side effect of nausea and occasional vomiting. The persistent hydramnios may well have been a contributory factor. Fetal progress was satisfactory as assessed by serial ultrasonic scanning-that is, scans of the biparietal diameter (Fig. 1 )-and repeated urinary oestriol estimations (Fig. 2) .
Maternal renal function was monitored by repeated urea and creatinine estimations and the calculation of 24-hour endogenous creatinine clearances (see Fig. 3 ). In mid-November when the pregnancy was at 36 weeks by dates and the fetal scans suggested a maturity of 35 + weeks the pregnancy was terminated by elective lower segment caesarean section. The diazoxide was discontinued 12 hours before operation. A normal looking 5-lb (2,270 g) male infant was delivered. The child required only minimal resuscitation and continued to thrive. The mother made a satisfactory recovery and was discharged 12 days later. At that time her blood pressure was 180/100 on no treatment and the serum creatinine had fallen to 1 0 mg/100 ml. Four weeks from delivery the blood pressure was 170/90. A year later her blood pressure was 180/90, on 0-5 g of chlorothiazide per day. (Pohl and Thurston, 1971) suggests the use of this therapy in uncontrollable hypertension of pregnancy.
Diazoxide is a non-diuretic bendrothiadiazine derivative with pronounced hypotensive properties (Finnerty, 1968) and tends to produce hyperglycaemia by inhibition of pancreatic insulin release (Dollery, 1962; Loubatieres et al., 1966) . This hyperglycaemia has been shown to respond to oral sulphonylurea therapy (Wolff, 1964) . Diazoxide lowers hypertensive blood pressures by producing generalized vasodilation (Nayler et al., 1968; Schmitt et al., 1968) . This would be expected to benefit the maternal renal blood flow and placental perfusion, and this is important since vasoconstriction would seem to be one of the mechanisms by which toxaemia of pregnancy may produce damage (Morris et al., 1955; Dixon et al., 1963) . It proved easy to maintain complete blood pressure control in our patients with oral diazoxide and prolongation of pregnancy by up to 10 weeks was achieved. The diminution or abolition of albuminuria which occurred in all four patients suggests at least an amelioration of the toxaemic process and this suggestion is further supported by the normal fetal growth which took place during the period of treatment. The successful conclusion of pregnancy in Case 1 despite the presence of considerable renal failure may well have been related to the increased renal blood flow which diazoxide is known to produce.
The only important side effect of oral diazoxide therapy that was encountered was sodium and fluid retention (Pohl et al., 1972) which responded satisfactorily to frusemide. The need for twice-daily blood sugar estimations made it necessary for the patients to stay in hospital for the remainder of pregnancy. Only Case 3 developed hyperglycaemia during the last week of diazoxide treatment. Although this was easily controlled by oral tolbutamide the cessation of fetal growth at this stage suggests that treatment with insulin would have been better. The reported effect of diazoxide in diabetics is variable (Graber et al., 1966; Black, 1968) . In our two diabetic patients (Cases 1 and 2) the effect was minimal and only trivial increases of insulin dosage were required. In the absence of hyperglycaemia oral diazoxide therapy cannot have impaired fetal endogenous insulin production since glucose tolerance tests on the newborn babies were normal (Milner, and Chouksey, 1972) .
The successful and yet fairly easy management of four cases of severe hypertension in pregnancy resistant to other therapy suggests to us that oral diazoxide deserves a trial in the management of this condition, but it is important to see and treat these patients early. We have seen other patients with much more severe hypertension, possibly antedating pregnancy, in which there has been an appreciable fetal mortality.
